A Study to Evaluate the Safety, Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA
This study has been completed.
Sponsor:
BioMarin Pharmaceutical
Information provided by:
BioMarin Pharmaceutical
ClinicalTrials.gov Identifier:
NCT00884949
First received: April 10, 2009
Last updated: July 15, 2011
Last verified: July 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2011 |
| Primary Completion Date: | February 2011 (Final data collection date for primary outcome measure) |